UmbREALung - A Retrospective and prospective, observational, real world multi-cohort study of patients with non-small cell lung cancer (NSCLC) initiating approved drugs developed by AZ or as part of an AZ alliance

Trial Identifier:	D4191R00060
Sponsor:	AstraZeneca
Start Date:	December 2024
Primary Completion Date:	June 2032
Study Completion Date:	June 2032

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
France	Aurillac, France
France	Chambery, France

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.